A legacy that inspires the Future.
Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices. For over 60 years, we’ve pioneered breakthrough products, interventions and solutions that improve patient outcomes and reduce the cost of care.
RAIN Sheath™ Transradial Thin-walled Introducer
The RAIN Sheath™ Transradial Thin-walled Introducer brings innovation in your hands with KINK RECOVERY TECHNOLOGY™. The proprietary sheath with elastomeric properties is designed to maintain lumen integrity.Discover More
RAILWAY™ Sheathless Access System
The RAILWAY™ Sheathless Access System is a versatile system for reducing access up to 2F1. This system features a smaller access profile than any radial sheath, and compatibility with a variety of guiding catheters.
1 Compared to conventional radial sheaths. Profile reduction is 1.2F compared to Terumo Glidesheath Slender.
MYNX CONTROL™ Vascular Closure Device
Closes with security. Leave nothing behind*. MYNX CONTROL™ Vascular Closure Devices integrate dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety and ease of use.
* The sealant is resorbed by the body within 30 daysDiscover More
Driven by mission, guided by values
Cordis is making a difference. We impact millions of lives, in more than 60 countries around the world. We embrace a diverse, empowered culture where teammates are inspired to serve customers, patients and shareholders while fulfilling their own career aspirations.
18 Apr 2022
Cordis Makes Strategic Investment in E2
Cordis Makes Strategic Investment in E2, a developer of Next-Generation Thrombectomy Devices Move signals new chapter of innovation for Cordis
5 Jan 2022
Cordis names Christopher Scully to CFO Post
Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Finan...
We’re here with the support and information to help you make the right decision for your patients.